These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15750929)

  • 1. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study.
    Oue T; Inoue M; Yoneda A; Kubota A; Okuyama H; Kawahara H; Nishikawa M; Nakayama M; Kawa K
    J Pediatr Surg; 2005 Feb; 40(2):359-63. PubMed ID: 15750929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
    Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
    Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening.
    Tanaka M; Kigasawa H; Kato K; Ijiri R; Nishihira H; Aida N; Ohama Y; Tanaka Y
    Pediatr Blood Cancer; 2010 Apr; 54(4):573-8. PubMed ID: 20049932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
    Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
    J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of mass-screened localized adrenal neuroblastoma.
    Iwanaka T; Yamamoto K; Ogawa Y; Arai M; Ito M; Kishimoto H; Hanada R; Imaizumi S
    J Pediatr Surg; 2001 Nov; 36(11):1633-6. PubMed ID: 11685689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal ganglioneuroblastoma resected 8 years after mass screening: a case report.
    Nakaoka T; Uemura S; Nakagawa Y; Yano T; Oda M
    J Pediatr Surg; 2007 Nov; 42(11):E29-32. PubMed ID: 18022424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic resection of an adrenal neuroblastoma detected by mass screening that grew in size during the observation period.
    Komuro H; Makino S; Tahara K
    Surg Endosc; 2000 Mar; 14(3):297. PubMed ID: 10854521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral adrenal neuroblastoma.
    Ishiguro Y; Iio K; Seo T; Nagaya M; Ito T
    Eur J Pediatr Surg; 1994 Feb; 4(1):37-9. PubMed ID: 8199131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ultrasound in managing neuroblastoma detected by mass screening: a proposed ultrasonographic grading for children with neuroblastoma.
    Hirata T; Tatara H; Zaizen Y; Suita S; Matsuzaki A; Ueda K
    J Clin Ultrasound; 1995 Jun; 23(5):305-13. PubMed ID: 7642769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal neuroblastoma: biologic behavior and surgical aspects.
    Hiyama E; Yokoyama T; Hiyama K; Yamaoka H; Matsuura Y; Nishimura Si; Ueda K
    Cancer; 2000 Apr; 88(8):1955-63. PubMed ID: 10760774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connatal localized neuroblastoma. The case to delay treatment.
    Kerbl R; Urban CE; Lackner H; Höfler G; Ambros IM; Ratschek M; Ambros PF
    Cancer; 1996 Apr; 77(7):1395-401. PubMed ID: 8608521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
    Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
    Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up results of the observation program for neuroblastoma detected at 6-month mass screening.
    Arakawa A; Oguma E; Aihara T; Kishimoto H; Kikuchi A; Hanada R; Koh K
    J Pediatr; 2014 Oct; 165(4):855-7.e1. PubMed ID: 25091258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Yonemori H; Hanai J; Kikuchi Y; Takasugi N
    Jpn J Clin Oncol; 1994 Oct; 24(5):247-51. PubMed ID: 7967103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment complications in children diagnosed with neuroblastoma during a screening program.
    Barrette S; Bernstein ML; Leclerc JM; Champagne MA; Samson Y; Brossard J; Woods WG
    J Clin Oncol; 2006 Apr; 24(10):1542-5. PubMed ID: 16575005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital stage 1 neuroblastoma evolved into stage 4s.
    Schiavetti A; Foco M; Ingrosso A; Chiriacò D; Ballesio L
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):59-60. PubMed ID: 19125091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.